Marieli Colon
Foot Surgery · Forest Park, GANPI 1407833015
Payments from drug & device makers
What this record shows
Triad Life Sciences Inc. accounts for 63.3% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $2,346 and has fallen 92.7% since, to $171 in 2025.
Across 45 payments — averaging $71.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Triad Life Sciences Inc.$2K
- Averitas Pharma Inc.$421
- Nevro Corp.$167
- Organogenesis Inc.$123
- Melinta Therapeutics, LLC$116
- GRT US Holding, Inc.$73
- plus $273 from 7 others
What the payments were for
- Travel & lodging$1,77055%
- Food & beverage$1,42745%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Triad Life Sciences Inc. | 5 | $2,024 |
| Averitas Pharma Inc. | 14 | $421 |
| Nevro Corp. | 2 | $167 |
| Organogenesis Inc. | 7 | $123 |
| Melinta Therapeutics, LLC | 1 | $116 |
| GRT US Holding, Inc. | 3 | $73 |
| Amgen | 4 | $73 |
| Convatec Inc. | 2 | $62 |
| Zyla Life Sciences, Inc. | 2 | $35 |
| Smith+Nephew | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Treace Medical Concepts, Inc. | 1 | $23 |
| Medtronic | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$1,909
- Omnia$128
- Baxdela$116
How this compares
Too few foot surgery providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 41 | $2,411 |
| Ammonium Lactate | 94 | $2,000 |
| Ciclopirox | 58 | $1,835 |
| Pregabalin | 70 | $1,289 |
| Gabapentin | 108 | $676 |
| Betamethasone Dipropionate | 12 | $403 |
| Ketoconazole | 20 | $370 |
| Prednisone | 18 | $234 |
| Terbinafine Hcl | 30 | $219 |
| Nystatin | 22 | $201 |
| Celecoxib | 18 | $180 |
| Methylprednisolone | 21 | $134 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $97 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $46 |
| Meloxicam | 21 | $25 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Forest Park
- Edward SzaboAugusta$4K
- Gemma EnglishBraselton$4K
- Ifeoma NwaedozieRome$3K
- Charles KeanAugusta$1K
- Anastasia ThomasStone Mountain$470
- Anthony GordonAthens$362
- Felicia PierreTucker$318
- Jessica BrownAtlanta$256
- Ebony ConnerPeachtree City$218
- Michael CantrellConyers$129
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.